Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer.
Beier AK, Ebersbach C, Siciliano T, Scholze J, Hofmann J, Hönscheid P, Baretton GB, Woods K, Guezguez B, Dubrovska A, Markowitsch SD, Thomas C, Puhr M, Erb HHH.
Beier AK, et al. Among authors: ebersbach c.
Oncogene. 2024 Jun;43(26):2038-2050. doi: 10.1038/s41388-024-03059-4. Epub 2024 May 15.
Oncogene. 2024.
PMID: 38750263
Free PMC article.